Beyond FDG: Other radioisotopes and radiopharmaceuticals used in PET-CT
This course explores other radioisotopes and radiopharmaceuticals less frequently used in PET-CT imaging to enhance radiographers’ and technologists’ knowledge about these lesser-known alternatives.
This e-learning course can be completed at your own pace and at a time and place to suit both you and your organisation’s requirements.
Learning Outcomes
- Describe the alternative radioisotopes and radiopharmaceuticals to FDG-18.
- Determine which radioisotopes and radiopharmaceuticals to use for each case.
- List the advantages and disadvantages of using each radioisotope and radiopharmaceutical.
-
Andrew Connolly
Andrew qualified as a radiographer in 1986, and then qualified to work in Nuclear Medicine in 1996. He has worked in 3 Nuclear Medicine departments and experienced a wide variety of scanning.
-
Rohit Kochhar
Dr Kochhar is a consultant oncoradiologist and a member of the UK National Cancer Research Institute (NCRI) Colorectal CSG with a specialist interest in peritoneal tumours, anal cancers and Education.